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Introduction {#embr201642586-sec-0001}
============

Acute inflammation at early developmental stages has been suggested to cause brain dysfunction by interfering with neuronal development [1](#embr201642586-bib-0001){ref-type="ref"}, [2](#embr201642586-bib-0002){ref-type="ref"}, [3](#embr201642586-bib-0003){ref-type="ref"}. Microbial infection, programmed cell death, tissue injury, and metabolic stress provide the sources for immune activation and trigger inflammatory responses [4](#embr201642586-bib-0004){ref-type="ref"}. Innate pattern recognition receptors (PRRs) are the first line of defense molecules to recognize pathogen‐associated molecular patterns (PAMPs) derived from foreign pathogens and that detect endogenous stress signals through interactions with danger‐associated molecular patterns (DAMPs) [5](#embr201642586-bib-0005){ref-type="ref"}. The major PRRs include Toll‐like receptors (TLRs), C‐type lectin receptors, retinoic acid‐inducible gene 1 (RIG‐I)‐like receptors, Nod‐like receptors (NLRs), and cytosolic DNA sensors [6](#embr201642586-bib-0006){ref-type="ref"}, [7](#embr201642586-bib-0007){ref-type="ref"}.

TLRs are the best‐characterized transmembrane PRRs that recognize various exogenous and endogenous molecular patterns [8](#embr201642586-bib-0008){ref-type="ref"}, [9](#embr201642586-bib-0009){ref-type="ref"}. TLR1, TLR2, TLR4, TLR5, TLR6, and TLR11 are expressed on cell surfaces and recognize microbial membrane components, whereas TLR3, TLR7, TLR8, and TLR9 are expressed in endosomes to detect both microbial and endogenous nucleic acids [6](#embr201642586-bib-0006){ref-type="ref"}, [8](#embr201642586-bib-0008){ref-type="ref"}. Among them, TLR3 is widely expressed in multiple cell types and specifically recognizes double‐strand RNA (dsRNA) derived from viruses and dead cells [4](#embr201642586-bib-0004){ref-type="ref"}, [8](#embr201642586-bib-0008){ref-type="ref"}, [10](#embr201642586-bib-0010){ref-type="ref"}, [11](#embr201642586-bib-0011){ref-type="ref"}, [12](#embr201642586-bib-0012){ref-type="ref"}. Unlike other TLRs that use MYD88 to transduce signaling, TLR3 only acts through TIR domain‐containing adapter‐inducing interferon‐β (TRIF) to trigger antiviral type I interferon and proinflammatory cytokine expression [7](#embr201642586-bib-0007){ref-type="ref"}, [8](#embr201642586-bib-0008){ref-type="ref"}.

TLR3 has been suggested to influence brain function in many aspects. The classical antiviral activity of TLR3 protects the brain from several neurotropic viral infections, for example, herpes simplex virus (HSV) and West Nile virus (WNV) [13](#embr201642586-bib-0013){ref-type="ref"}. In addition to its canonical role in antiviral infection, TLR3 activation negatively regulates neural progenitor cell proliferation and axonal growth of dorsal root ganglia neurons [14](#embr201642586-bib-0014){ref-type="ref"}, [15](#embr201642586-bib-0015){ref-type="ref"}, suggesting roles for TLR3 in neurodevelopment. Indeed, TLR3 activation by virus invasion or administration of poly(I:C)---a synthetic dsRNA---at the early developmental stage increases the possibility of developing a psychiatric disorder such as autism or schizophrenia [1](#embr201642586-bib-0001){ref-type="ref"}, [3](#embr201642586-bib-0003){ref-type="ref"}, [16](#embr201642586-bib-0016){ref-type="ref"}. Moreover, using a mouse genetic model, research has further indicated that, in the absence of an immune challenge, *Tlr3* deletion enhances hippocampal‐dependent learning and memory, impairs amygdala‐related behavior, and increases anxiety [17](#embr201642586-bib-0017){ref-type="ref"}. Therefore, TLR3 acts as a sensor to detect exogenous pathogens, as well as endogenous developmental or stress signals, to modulate neural development and function.

Peripheral immune responses induced by TLR3 activation have been suggested as being involved in the regulation of neuronal development and brain function [18](#embr201642586-bib-0018){ref-type="ref"}, [19](#embr201642586-bib-0019){ref-type="ref"}. However, accumulated studies indicate that TLR3 is expressed in neural progenitors, sensory neurons, and hippocampal and cortical neurons [14](#embr201642586-bib-0014){ref-type="ref"}, [15](#embr201642586-bib-0015){ref-type="ref"}, [20](#embr201642586-bib-0020){ref-type="ref"}, [21](#embr201642586-bib-0021){ref-type="ref"}, [22](#embr201642586-bib-0022){ref-type="ref"}, with the evidence suggesting that poly(I:C) can directly activate TLR3 in neurons to control neuronal development, though the molecular mechanism is still unclear. Here, we used various mouse genetic models, combined with *in vivo* and *in vitro* poly(I:C) stimulation, to investigate the function and signaling of TLR3 activation in neuronal morphogenesis. Our results show that TLR3 uses a MYD88‐dependent pathway to regulate expression of a series of psychiatric disorder‐related genes, including *Disc1*, and subsequently influences neuronal development.

Results {#embr201642586-sec-0002}
=======

TLR3 activation impairs neuronal morphogenesis {#embr201642586-sec-0003}
----------------------------------------------

To study the regulation of neuronal morphology by TLR3, we used GFP‐transfected cortical and hippocampal mixed cultures. The GFP signals were used to outline neuronal morphology. Neurons were treated with poly(I:C) at 2 days *in vitro* (DIV) and 5 DIV for 24 h. Echoing a previous study [15](#embr201642586-bib-0015){ref-type="ref"}, poly(I:C) treatment impaired axonal growth at 3 DIV in our system (Fig [1](#embr201642586-fig-0001){ref-type="fig"}A). Moreover, we found that both dendritic length and tip number were reduced after poly(I:C) treatment (Fig [1](#embr201642586-fig-0001){ref-type="fig"}B). The *in vitro* effect of poly(I:C) on axonal growth and dendritic arborization was mediated by TLR3, because *Tlr3* ^−/−^ neurons did not respond to poly(I:C) (Fig [1](#embr201642586-fig-0001){ref-type="fig"}C). We then investigated the effect of TLR3 activation on neuronal morphogenesis *in vivo*. *Thy1*‐*Yfp* transgenic mice received an intraperitoneal injection of saline or poly(I:C) at P4 and P5, and neuron morphology was monitored at P7. At P7, the *Thy1*‐*Yfp* transgene was only expressed in a few projection neurons in the retrosplenial granular cortex (RGC) and caudal hippocampal regions. Based on the YFP signals, we found that systemic administration of poly(I:C) impaired dendritic arborization of the RGC neurons, which was reflected in shorter total dendritic length, fewer branch tips, and a reduced intersection number in Sholl analysis (Fig [1](#embr201642586-fig-0001){ref-type="fig"}D). The *in vivo* effect of poly(I:C) on dendritic arborization also depended on TLR3, since poly(I:C) did not inhibit dendritic growth of *Tlr3* ^−/−^ mice (Fig [1](#embr201642586-fig-0001){ref-type="fig"}E). These results suggest that TLR3 activation impairs neuronal morphology *in vitro*, as well as *in vivo*.

![TLR3 activation negatively regulates neuronal morphogenesis *in vivo* and *in vitro*\
A, BPoly(I:C) treatment inhibits axonal growth at 3 DIV (A) and dendritic growth at 6 DIV (B) in WT neurons. Neurons were transfected with GFP at 1 or 4 DIV. One day later, neurons were treated with poly(I:C) for 24 h before harvest.CAxon and dendrite morphology of *Tlr3* ^−/−^ neurons after poly(I:C) treatment.D, ENeuronal morphology in saline‐ and poly(I:C)‐treated *Tlr3* ^+/+^ *;Thy1‐Yfp* (D) and *Tlr3* ^−/−^;*Thy1‐Yfp* (E) mouse brains. Total dendrite length, dendritic tip number, and Sholl analysis of dendritic processes were used to examine the dendrite phenotype.Data information: (A--C) Data were analyzed by unpaired *t*‐test. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. (D, E) Data of dendrite length and tip number were analyzed by unpaired *t*‐test. The Sholl data were analyzed by two‐way ANOVA with Bonferroni\'s multiple comparison test. The numbers of analyzed neurons and mice are presented in each column. Mean values ± SEM are shown. \**P* \< 0.05, \*\**P* \< 0.001, \*\*\**P* \< 0.0001. Scale bar: 20 μm in (A) and (B), 50 μm in (D) and (E).](EMBR-18-169-g002){#embr201642586-fig-0001}

MYD88 acts downstream of TLR3 in controlling dendritogenesis {#embr201642586-sec-0004}
------------------------------------------------------------

To investigate the downstream pathway of TLR3 in controlling dendritic arborization, *Trif*‐mutant [23](#embr201642586-bib-0023){ref-type="ref"} and *Myd88* ^−/−^ [24](#embr201642586-bib-0024){ref-type="ref"} neurons were treated with poly(I:C). Unexpectedly, although *Trif* mutation impaired the cytokine production triggered by TLR3 activation (Fig [EV1](#embr201642586-fig-0001ev){ref-type="fig"}), *Trif*‐mutant neurons still had shorter dendrites and fewer dendritic tips in the presence of poly(I:C) (Fig [2](#embr201642586-fig-0002){ref-type="fig"}A). For *Myd88* ^−/−^ mice, the production of peripheral inflammatory cytokines is greatly reduced in response to TLR activation [24](#embr201642586-bib-0024){ref-type="ref"}. *Myd88* ^−/−^ neurons also lost the response to TLR7 activation [20](#embr201642586-bib-0020){ref-type="ref"}, indicating that Myd88 is indeed functionally ablated in knockout mice. Here, we found that, similar to TLR7 activation, *Myd88* ^−/−^ neurons also did not respond to TLR3 activation via poly(I:C) treatment (Fig [2](#embr201642586-fig-0002){ref-type="fig"}B), suggesting that MYD88 is required for TLR3 to inhibit dendritic growth. To further confirm the roles of MYD88 and TRIF in dendritic growth, MYD88 and TRIF were overexpressed in cultured neurons. We found that only MYD88 overexpression was able to shorten the dendritic length (Fig [2](#embr201642586-fig-0002){ref-type="fig"}C), suggesting that MYD88 overexpression triggers the downstream signaling to shorten dendritic length.

![*Trif*‐mutant neurons lose the response to poly(I:C) stimulation\
At 5 DIV, *Trif*‐mutant neurons were treated with poly(I:C) for 6 h, RNAs were extracted, and the expression levels of *Tnfa*,*Ifnb*, and *Il1b* were examined by using quantitative RT‐PCR. The scales of *y*‐axes are identical to those in Fig [4](#embr201642586-fig-0004){ref-type="fig"}A for the responses of wild‐type neurons to poly(I:C) and saline control. For *Ifnb*, the expression levels in response to poly(I:C) decreased dramatically from 100‐fold to 4‐fold relative to *Hprt* transcripts when comparing wild‐type and *Trif*‐mutant neurons; although, compared with saline control, poly(I:C) still increased *Ifnb* expression in *Trif*‐mutant neurons. Data were analyzed by unpaired *t*‐test. *N* = 6. Mean values ± SEM are shown. \*\**P* \< 0.001.](EMBR-18-169-g003){#embr201642586-fig-0001ev}

![TLR3 acts through MYD88 to regulate neuronal morphology\
A, BQuantitation of dendrite morphology of *Trif*‐mutant neurons (A) and *Myd88* ^−/−^ neurons (B) after poly(I:C) stimulation. *Trif*‐mutant or *Myd88* ^−/−^ neurons were transfected with a GFP construct at 4 DIV and treated with poly(I:C) 1 day later. Neuron morphology was analyzed at 6 DIV according to the GFP signal. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by unpaired *t*‐test.CMYD88, but not TRIF, expression reduces dendrite outgrowth. HA‐tagged MYD88 and TRIF were cotransfected with a GFP construct into cultured wild‐type (WT) neurons at 4 DIV, and cell morphology was analyzed at 6 DIV. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by one‐way ANOVA with Bonferroni\'s multiple comparison test.DMYD88 knockdown, but not TRIF knockdown, robustly increases dendritic arbors and loses the response to poly(I:C). Three DIV neurons were transfected with control shRNA (shCtrl), MYD88 shRNA (shMYD88), or TRIF shRNA (shTRIF) and poly(I:C) was applied into the culture at 5 DIV for 24 h before harvest. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni\'s multiple comparison test.Data information: Scale bars, 20 μm. \*\*\**P* \< 0.0001. See also Figs [EV1](#embr201642586-fig-0001ev){ref-type="fig"} and [EV2](#embr201642586-fig-0002ev){ref-type="fig"}.](EMBR-18-169-g004){#embr201642586-fig-0002}

The effect of MYD88 on dendritic growth was also investigated by transfecting wild‐type neurons with the knockdown construct shMYD88. We found that MYD88 knockdown in cultured neurons was sufficient to promote dendritic growth (Fig [2](#embr201642586-fig-0002){ref-type="fig"}D), suggesting the presence of intrinsic stimulants in the culture that downregulate dendritic growth via MYD88. Addition of poly(I:C) did not shorten the dendritic length of MYD88‐knockdown neurons, echoing the results from *Myd88* ^−/−^ neurons showing that the effect of poly(I:C) on dendritic growth is mediated by MYD88. In contrast to MYD88, TRIF knockdown did not influence dendritic growth (Fig [2](#embr201642586-fig-0002){ref-type="fig"}D) and poly(I:C) treatment still restricted dendritic growth of TRIF‐knockdown neurons (Fig [2](#embr201642586-fig-0002){ref-type="fig"}D). The knockdown effects of MYD88 shRNA and TRIF shRNA on MYD and TRIF expression are shown in Fig [EV2](#embr201642586-fig-0002ev){ref-type="fig"}. Together, these results suggest that TLR3 activation by poly(I:C) uses a MYD88‐dependent pathway to inhibit dendritic growth.

![The knockdown efficiency of MYD88‐ and TRIF‐knockdown constructs\
A, BNon‐silencing control shRNA (shCtrl), MYD88 shRNA (shMYD88), or TRIF shRNA (shTRIF) was cotransfected with HA‐tagged MYD88 or HA‐TRIF into HEK293T cells. Twenty‐four hours later, total cell extract was collected and subjected to immunoblot analysis. The effects of (A) shMYD88 and (B) shTRIF are shown. Immunoblotting was performed with HA tag and β‐actin antibodies. β‐Actin was used as a loading control. Molecular mass standards (kD) are indicated next to the gel blots.](EMBR-18-169-g005){#embr201642586-fig-0002ev}

The N‐terminal region of MYD88 is critical for TLR3 signaling {#embr201642586-sec-0005}
-------------------------------------------------------------

TLRs typically deliver the signals to their downstream TIR domain‐containing adaptor via a direct protein--protein interaction of the TIR domains [25](#embr201642586-bib-0025){ref-type="ref"}. To further investigate the role of MYD88 in the TLR3 pathway, we examined the interaction between TLR3 and MYD88 using coimmunoprecipitation. In HEK293 cells, Myc‐tagged full‐length TLR3, but not the ectodomain of TLR3, was coprecipitated with HA tag antibody in the presence of HA‐tagged MYD88 (Fig [3](#embr201642586-fig-0003){ref-type="fig"}A), suggesting a specific interaction between the cytoplasmic domain of TLR3 and MYD88. In addition, this interaction was enhanced in the presence of poly(I:C), as there was more TLR3 associated with the MYD88 immunocomplex upon poly(I:C) stimulation (Fig [3](#embr201642586-fig-0003){ref-type="fig"}B). Although the TIR domain of MYD88 is the region that interacts with various TLRs [26](#embr201642586-bib-0026){ref-type="ref"}, we found that the C‐terminal TIR domain of MYD88 was not coprecipitated with TLR3 (Fig [3](#embr201642586-fig-0003){ref-type="fig"}C). Instead, the N‐terminal region of MYD88 that contains the death and intermediate domains precipitated with TLR3 (Fig [3](#embr201642586-fig-0003){ref-type="fig"}C). These results suggest that MYD88 uses a special mechanism to interact with TLR3.

![TLR3 interacts with MYD88\
Coimmunoprecipitation of TLR3 and MYD88. HEK293T cells were transfected with the indicated constructs. Twenty‐four hours later, immunoprecipitation (IP) was performed using HA antibody. The precipitates were immunoblotted (IB) with Myc and HA antibodies as indicated. EC, TLR3 ectodomain.Poly(I:C) treatment increases the interaction between TLR3 and MYD88. One day after transfection, cells were treated with saline or poly(I:C) for 30 min before harvesting.Upper, schematic of MYD88 constructs. DD, death domain; ID, intermediate domain; TIR, TIR domain. Lower, coimmunoprecipitation of TLR3 and the N‐terminal region of MYD88. For (A--C), representatives of three independent experiments are shown.Full‐length and N‐terminal MYD88 inhibit dendrite outgrowth. *Myd88* ^−/−^ neurons were transfected with control vector (Ctrl), HA‐tagged MYD88 (MYD88), N‐terminal MYD88 (MYD88‐N), or C‐terminal MYD88 (MYD88‐C) with a GFP construct. Poly(I:C) was applied into the culture at 5 DIV and neuronal morphology was analyzed at 6 DIV. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni\'s multiple comparison test. \*\*\**P* \< 0.0001. Scale bar, 20 μm.Expression patterns of full‐length and truncated fragments of MYD88 in *Myd88* ^−/−^ neurons. Representative images are shown. Scale bar, 20 μm.](EMBR-18-169-g006){#embr201642586-fig-0003}

To further investigate the role of the MYD88 N‐terminal region in neurons, we transfected MYD88‐N, MYD88‐C, and full‐length constructs into *Myd88* ^−/−^ neurons and monitored their effects on dendritic growth. We found that, similar to wild‐type neurons (Fig [2](#embr201642586-fig-0002){ref-type="fig"}C), Myd88 overexpression in *Myd88* ^−/−^ neurons reduced dendritic length (Fig [3](#embr201642586-fig-0003){ref-type="fig"}D). Poly(I:C) treatment did not further shorten dendritic length, supporting that poly(I:C) and MYD88 act on the same pathway to regulate dendritic growth. MYD88‐N exhibited a similar pattern as full‐length MYD88 in regulating dendritic growth (Fig [3](#embr201642586-fig-0003){ref-type="fig"}D), suggesting the essential and sufficient role of the N‐terminal region of MYD88 for dendritic regulation. In contrast to MYD88‐N and full‐length proteins, MYD88‐C did not have an effect on dendritic length, either in the presence or in the absence of poly(I:C) (Fig [3](#embr201642586-fig-0003){ref-type="fig"}D). These data strengthen our evidence for the function of the N‐terminal region of MYD88 in controlling dendritic growth.

When we analyzed the *Myd88* constructs in neurons, we noticed that full‐length MYD88 formed aggregates in neurons (Fig [3](#embr201642586-fig-0003){ref-type="fig"}E). For MYD88‐N, \~70--80% of transfected cells also contained MYD88‐N aggregates (Fig [3](#embr201642586-fig-0003){ref-type="fig"}E, MYD88‐N (1)). In the remaining 20--30% of transfected cells, MYD88‐N tended to concentrate at the edges of soma and entire dendritic processes (Fig [3](#embr201642586-fig-0003){ref-type="fig"}E, MYD88‐N (2)). MYD88‐C was always evenly distributed in neurons (Fig [3](#embr201642586-fig-0003){ref-type="fig"}E). Previous study has shown that MYD88 aggregation via its N‐terminal death domain is required for its activation and signal delivery to the downstream kinases [27](#embr201642586-bib-0027){ref-type="ref"}, [28](#embr201642586-bib-0028){ref-type="ref"}. Formation of protein aggregates suggests that overexpression of full‐length and the N‐terminal region of MYD88 in neurons is sufficient to activate the MYD88 downstream pathway, consistent with the aforementioned finding that overexpression of full‐length and the N‐terminal region of MYD88 restricted dendritic growth (Fig [3](#embr201642586-fig-0003){ref-type="fig"}D).

Cytokines are not required for the effect of TLR3 on neurons {#embr201642586-sec-0006}
------------------------------------------------------------

In general, TLR activation triggers expression of inflammatory and/or antiviral cytokines [5](#embr201642586-bib-0005){ref-type="ref"}. A previous study showed that addition of these cytokines to cultured neurons impairs dendritic growth [29](#embr201642586-bib-0029){ref-type="ref"}. We wondered whether cytokines are involved in the function of TLR3 in dendritic morphogenesis. Upon poly(I:C) stimulation, the RNA levels of *Tnfa*,*Il‐1β*, and *Ifnb* increased, but *Il6* was not upregulated (Fig [4](#embr201642586-fig-0004){ref-type="fig"}A). To investigate the roles of these cytokines, two sets of experiments were performed. The first one was to use poly(I:C) to stimulate *Tnfa* ^−/−^ neurons. *Il6* ^−/−^ neurons were also included as a negative control, since TLR3 activation did not induce *Il6* expression in cultured neurons. The results showed that poly(I:C) still effectively inhibited dendritic growth of these cytokine‐deficient neurons (Fig [4](#embr201642586-fig-0004){ref-type="fig"}B and C), suggesting that IL‐6, as well as TNF‐α, is not critical for TLR3‐regulated dendritic growth. However, it is still possible that TLR3 activation induces expression of other cytokine(s) rather than TNF‐α to control dendritic growth. Therefore, we performed a second experiment using conditioned medium, which investigated whether neurons secrete cytokines into the culture medium to inhibit dendritic growth. Using conditioned medium, our previous study demonstrated that neuronal TLR7 activation promotes IL‐6 secretion and then inhibits dendritic growth [20](#embr201642586-bib-0020){ref-type="ref"}. Here, the same experimental design was applied to explore whether TLR3 activation stimulates secretion of unknown factors into the medium to downregulate dendritic growth (Fig [4](#embr201642586-fig-0004){ref-type="fig"}D, left panel). The conditioned medium of poly(I:C)‐treated neurons was collected and applied to naïve recipient neurons (Fig [4](#embr201642586-fig-0004){ref-type="fig"}D, left panel). In WT recipient neurons, poly(I:C)‐treated conditioned medium inhibited dendritic growth, just like for the results of neurons treated directly with poly(I:C) (Fig [4](#embr201642586-fig-0004){ref-type="fig"}D, right upper panel). However, we were concerned that the residual poly(I:C) in the conditioned medium was still able to activate the TLR3 of recipient neurons and result in dendritic shortening. To examine this possibility, we added the conditioned medium to *Tlr3* ^−/−^ neurons and found that the poly(I:C)‐treated conditioned medium was unable to inhibit dendritic growth of *Tlr3* ^−/−^ neurons (Fig [4](#embr201642586-fig-0004){ref-type="fig"}D, right lower panel). These results suggest that TLR3 activation does not use secreted factor(s) to negatively control dendritic growth.

![TLR3 activation does not use secreted factors to regulate neuronal morphology\
AQuantitative RT‐PCR analysis of proinflammatory cytokines *Il6*,*Tnfa*,*Il1b* and antiviral cytokine *Ifnb* in WT cultured cortical and hippocampal neurons. Data were analyzed by unpaired *t*‐test. *Il6* and *Tnfa*,*N* = 8; *Ifnb* and *Il1b*,*N* = 6.B, CPoly(I:C) treatment inhibits dendrite outgrowth of *Il6* ^−/−^ neurons (B) and *Tnfa* ^−/−^ neurons (C).DLeft, schematic of experiment using conditioned medium. Upper right, conditioned medium applied to WT neurons. Lower right, conditioned medium applied to *Tlr3* ^−/−^ neurons. Dendrite morphology was analyzed 1 day after adding conditioned medium.Data information: Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by unpaired *t*‐test. \**P* \< 0.05, \*\*\**P* \< 0.0001.](EMBR-18-169-g008){#embr201642586-fig-0004}

TLR3 activation cell‐autonomously regulates dendritogenesis {#embr201642586-sec-0007}
-----------------------------------------------------------

The aforementioned results suggest that a secreted factor is not involved in the effect of TLR3 on dendritic morphology. It seems possible that TLR3 activation acts cell‐autonomously to control neuronal morphology. To address the possibility, we applied TLR3 shRNA (shTLR3) to reduce TLR3 expression (Fig [EV3](#embr201642586-fig-0003ev){ref-type="fig"}). Since the knockdown construct coexpresses GFP, we can use GFP signal to identify the transfected neurons and outline neuronal morphology. Given that transfection efficiency in our neuronal cultures is \< 1%, shTLR3‐transfected neurons are expected to be surrounded by many non‐transfected cells that still secrete cytokines in response to poly(I:C) stimulation. Therefore, TLR3‐knockdown neurons are still exposed to cytokines upon poly(I:C) treatment. For neurons transfected with non‐silencing control shCtrl [30](#embr201642586-bib-0030){ref-type="ref"}, poly(I:C) treatment obviously restricted dendritic growth (Fig [5](#embr201642586-fig-0005){ref-type="fig"}). For shTLR3‐expressing neurons, poly(I:C) treatment did not shorten dendritic length (Fig [5](#embr201642586-fig-0005){ref-type="fig"}), supporting that secreted factors do not cause dendritic growth deficits under poly(I:C) treatment and that TLR3 activation acts cell‐autonomously to downregulate dendritic growth. Note that, similar to MYD88 knockdown (Fig [2](#embr201642586-fig-0002){ref-type="fig"}D), TLR3 knockdown resulted in longer dendrites compared with control shCtrl (Fig [5](#embr201642586-fig-0005){ref-type="fig"}), which also indicates the presence of an intrinsic ligand for TLR3 in the cultures. Because both mRNAs and the microtubule‐binding protein, stathmin, have been shown to serve as intrinsic ligands of TLR3 [12](#embr201642586-bib-0012){ref-type="ref"}, [31](#embr201642586-bib-0031){ref-type="ref"}, dead cells in the cultures likely provide intrinsic stimulants to activate TLR3 and restrict dendritic growth. When TLR3 expression levels were reduced, knockdown neurons became unresponsive to the intrinsic ligands and grew better. Our previous study of TLR7 also indicated that neuronal TLR7 recognizes single‐stranded RNA in cultures and restricts dendritic growth [20](#embr201642586-bib-0020){ref-type="ref"}. Thus, both TLR7 and TLR3 are able to use a cell‐autonomous mechanism to regulate dendritic growth.

![The effect of the TLR3‐knockdown construct on TLR3 expression\
Control shRNA (shCtrl) or TLR3 shRNA (shTLR3) was cotransfected with Myc‐tagged TLR3 into HEK293T cells. Total cell extract was collected 24 h later and subjected to immunoblot analysis. Immunoblotting was performed with Myc tag and α‐tubulin antibodies. α‐Tubulin was used as a loading control.](EMBR-18-169-g007){#embr201642586-fig-0003ev}

![TLR3 knockdown in neurons promotes dendrite outgrowth and is resistant to poly(I:C) stimulation\
At 4 DIV, cultured cortical neurons were transfected with indicated plasmids. Three days later, neurons were treated with 10 μg/ml poly(I:C) for 24 h. Neuronal morphology was monitored by GFP signals at 8 DIV. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni\'s multiple comparison test. Scale bar, 20 μm. \*\*\**P* \< 0.0001, ns: non‐significant. See also Fig [EV3](#embr201642586-fig-0003ev){ref-type="fig"}.](EMBR-18-169-g010){#embr201642586-fig-0005}

TLR3 regulates expression of psychiatric disease genes {#embr201642586-sec-0008}
------------------------------------------------------

TLR3 activation at early developmental stages induces autism‐ and schizophrenia‐like behavior [32](#embr201642586-bib-0032){ref-type="ref"}. Our aforementioned results also suggest that TLR3 activation in neurons restricts dendritic growth. Therefore, we wondered whether TLR3 activation alters the expression of genes that regulate neuronal morphology and also are associated with schizophrenia and/or autism. Quantitative RT--PCR was used to determine the expression levels of several autism‐ or schizophrenia‐related genes in response to poly(I:C) stimulation, namely *Auts2*,*Cdh8*,*Disc1*,*Fmr1*,*Mecp2*,*Nrg1*,*Nrxn1*,*Pten*,*Shank3*,*Tbr1*,*Tsc1*, and *Ube3a* ([Table EV1](#embr201642586-sup-0002){ref-type="supplementary-material"}). We found that except for *Cdh8*,*Mecp2*, and *Tsc1*, all remaining nine genes in the list were downregulated in cultured cortical and hippocampal neurons upon poly(I:C) stimulation (Fig [6](#embr201642586-fig-0006){ref-type="fig"}A). To confirm that the reduced expression of these genes is mediated by TLR3, the effect of poly(I:C) was examined using *Tlr3* ^−/−^ neurons. The expression of *Nrg1*,*Nrxn1*,*Shank3*, and *Tbr1* genes was still reduced in *Tlr3* ^−/−^ neurons upon poly(I:C) treatment (Fig [6](#embr201642586-fig-0006){ref-type="fig"}B), suggesting that TLR3 is not required for the effect of poly(I:C) on reducing *Nrg1*,*Nrxn1*,*Shank3*, and *Tbr1* expression. It also indicates that only *Auts2*,*Disc1*,*Fmr1*,*Pten*, and *Ube3a* were specifically regulated by TLR3 activation (Fig [6](#embr201642586-fig-0006){ref-type="fig"}B). In *Myd88* ^−/−^ neurons, poly(I:C) treatment did not noticeably influence expressions of *Auts2*,*Disc1*,*Fmr1*,*Pten*, and *Ube3a* (Fig [6](#embr201642586-fig-0006){ref-type="fig"}C), consistent with the role of MYD88 in the TLR3 pathway. The *in vivo* expression of these five genes was further investigated by injection of poly(I:C) into P5 mice. We found that *Auts2*,*Disc1*,*Fmr1*, and *Ube3a* still had lower RNA expression levels in poly(I:C)‐treated mouse brains (Fig [6](#embr201642586-fig-0006){ref-type="fig"}D), indicating the role of TLR3 in controlling the expression of these autism‐ and schizophrenia‐related genes in brains.

![TLR3 activation downregulates expression of neuropsychiatric disorder‐related genes\
AExpression of 12 neuropsychiatric disorder‐related genes in saline‐ and poly(I:C)‐treated WT neurons.BExpression of nine neuropsychiatric disorder‐related genes in poly(I:C)‐treated *Tlr3* ^−/−^ neurons. Relative expression levels compared with vehicle control are shown. Dashed line indicates the level of saline control.C, DExpression of *Aust2*,*Disc1*,*Fmr1*,*Pten,* and *Ube3a* in poly(I:C)‐treated *Myd88* ^−/−^ neurons (C) and poly(I:C)‐treated P5 WT mouse brains (D). Similar to (B), relative levels compared with vehicle control are shown. Dashed lines indicate the level of saline control.EDIV 5 WT neurons were treated with poly(I:C) for 24 h. The total neuronal lysates were subjected to immunoblotting with the indicated antibodies. VCP and β‐actin were used as loading controls. The protein levels were normalized with β‐actin.Data information: Mean values ± SEM are shown. Data were analyzed by unpaired *t*‐test. \**P* \< 0.05, \*\**P* \< 0.001, \*\*\**P* \< 0.0001. Numbers of experimental repeats (*N*) are indicated. *N* = 6 in (A--C) and *N* = 5 in (D). See also Figs [EV4](#embr201642586-fig-0004ev){ref-type="fig"} and [EV5](#embr201642586-fig-0005ev){ref-type="fig"}.](EMBR-18-169-g012){#embr201642586-fig-0006}

We further examined the protein levels of the aforementioned genes 24 h after poly(I:C) treatment, that is, the time‐point for monitoring dendritic morphology. Only DISC1 protein levels were obviously lower upon poly(I:C) stimulation (Fig [6](#embr201642586-fig-0006){ref-type="fig"}E). Moreover, the reduction in DISC1 protein levels was also dependent on TLR3 and MYD88, because poly(I:C) did not influence the DISC1 levels in *Tlr3* ^−/−^ and *Myd88* ^−/−^ neurons (Fig [EV4](#embr201642586-fig-0004ev){ref-type="fig"}). In addition, the results of immunostaining indicated that, similar to poly(I:C) treatment, MYD88 overexpression in neurons reduced DISC1 protein levels (Fig [EV5](#embr201642586-fig-0005ev){ref-type="fig"}). Together, these results suggest that TLR3 activation reduces *Disc1* expression in neurons in a MYD88‐dependent manner.

![Poly(I:C) does not alter DISC1 protein levels in *Tlr3* ^−/−^ neurons or *Myd88* ^−/−^ neurons\
A, BAt 5 DIV, *Tlr3* ^−/−^ (A) and *Myd88* ^−/−^ (B) neurons were treated with poly(I:C) for 24 h. The total neuronal lysates were subjected to immunoblotting with the indicated antibodies. VCP and β‐actin were used as loading controls.](EMBR-18-169-g009){#embr201642586-fig-0004ev}

![Poly(I:C) treatment and MYD88 overexpression reduce the DISC1 protein levels in neurons\
Neurons were transfected with control vector (Ctrl) or HA‐MYD88 (MYD88) with a GFP construct at 4 DIV. One day later, neurons were treated with saline or 10 μg/ml poly(I:C) for 24 h. Neurons were fixed and immunostained with DISC1 antibody at 6 DIV. Counterstaining with DAPI was performed to label the nuclei. DISC1 signal within the soma region (white dashed line as indicated) was quantified using ImageJ. The data were reproduced in two independent experiments. Only one set of representative data is shown. The dots indicate the relative DISC1 intensities of individual cells. The bars indicate mean of each group. Data were analyzed by one‐way ANOVA followed by Bonferroni\'s multiple comparison test. Ctrl − pIC versus Ctrl + pIC, *P* \< 0.0001; Ctrl − pIC versus MYD88 − pIC, *P* \< 0.0001. Scale bar, 20 μm.](EMBR-18-169-g011){#embr201642586-fig-0005ev}

DISC1 acts downstream of TLR3 in regulating dendritic growth {#embr201642586-sec-0009}
------------------------------------------------------------

We then investigated the functional role of DISC1 in TLR3‐dependent neuronal morphogenesis by overexpression of DISC1 in poly(I:C)‐treated neurons. Neurons overexpressing DISC1 were resistant to poly(I:C) treatment, as the total dendrite lengths and total numbers of dendritic branch tips of poly(I:C)‐treated *Disc1*‐transfected neurons were comparable with those of neurons treated with vehicle controls with or without DISC1 overexpression (Fig [7](#embr201642586-fig-0007){ref-type="fig"}A). The mouse DISC1 L604F mutant, which corresponds to the human DISC1 L607F mutant that is a common missense variant in schizophrenia patients [33](#embr201642586-bib-0033){ref-type="ref"}, [34](#embr201642586-bib-0034){ref-type="ref"}, was unable to rescue the dendritic defects caused by TLR3 activation (Fig [7](#embr201642586-fig-0007){ref-type="fig"}A), further suggesting the specific effect of DISC1 on the TLR3 pathway. In addition to the *in vitro*‐cultured neurons, we also applied *in utero* electroporation to investigate the rescue effect of DISC1 overexpression in brains. Similar to the results of *Thy1‐Yfp* mice (Fig [1](#embr201642586-fig-0001){ref-type="fig"}D), poly(I:C) treatment reduced the complexity of dendritic arbors in the layer 2/3 cortical neurons labeled with GFP by *in utero* electroporation (Fig [7](#embr201642586-fig-0007){ref-type="fig"}B). With additional DISC1 expression, the neurons had comparable dendrite length, dendritic tip number, and dendritic complexity in the saline‐ and poly(I:C)‐treated mice (Fig [7](#embr201642586-fig-0007){ref-type="fig"}C). These results demonstrate that DISC1 is critical for the effect of TLR3 activation on downregulation of dendritic morphogenesis.

![DISC1 overexpression rescues the effects of TLR3 activation on dendritic arborization *in vitro* and *in vivo*\
AOverexpression of WT DISC1, but not the DISC1 L604F mutant, in cultured neurons suppresses dendrite withdrawal induced by TLR3 activation. Mean values ± SEM of representatives of three independent experiments are shown. The numbers of analyzed neurons in the representative experiments are indicated in each column. Data were analyzed by two‐way ANOVA with Bonferroni\'s multiple comparison test. Scale bars, 20 μm. \*\**P* \< 0.001, \*\*\**P* \< 0.0001.B, COverexpression of DISC1 in cortical neurons of mouse brain is resistant to poly(I:C)‐triggered reduction in dendritic arborization. Vector control (Ctrl) (B) or Myc‐DISC1 (C) was coexpressed with GFP in cortical layer 2/3 neurons in mouse brain. After poly(I:C) injection at P4 and P5, the neuronal morphology was analyzed at P7 by tracing the GFP signals. The data of dendrite length and tip number were analyzed by unpaired *t*‐test. The Sholl data were analyzed by two‐way ANOVA with Bonferroni\'s multiple comparison test. The numbers of analyzed neurons collected from 3 to 4 mice of each group are indicated. Mean values ± SEM are shown. Scale bar, 30 μm. \**P* \< 0.05, \*\*\**P* \< 0.0001.](EMBR-18-169-g013){#embr201642586-fig-0007}

In conclusion, these results support that TLR3 activation regulates expression of *Disc1* to control dendritic arborization.

TLR3 activation impairs dendritic spinogenesis {#embr201642586-sec-0010}
----------------------------------------------

We further investigated whether TLR3 activation also regulates dendritic spine formation. In cortical and hippocampal mixed cultures, poly(I:C) treatment increased dendritic spine density, but narrowed the spine heads at 18 DIV (Fig [8](#embr201642586-fig-0008){ref-type="fig"}A), suggesting that TLR3 activation alters dendritic spine formation. To further confirm this effect *in vivo*, we intraperitoneally injected poly(I:C) or saline vehicle control into *Thy1‐Yfp* mice at P4 and P5 and characterized dendritic spines of layer 5 pyramidal neurons of the somatosensory cortex at P21 (Fig [8](#embr201642586-fig-0008){ref-type="fig"}B). After being stimulated with poly(I:C), dendritic spine density was increased, whereas spine heads tended to be smaller (Fig [8](#embr201642586-fig-0008){ref-type="fig"}C), which is similar to what we observed in cultured neurons (Fig [8](#embr201642586-fig-0008){ref-type="fig"}A). The effect of poly(I:C) on dendritic spine density and size was TLR3‐specific, because dendritic spines of *Tlr3* ^−/−^ mice were not altered by poly(I:C) treatment (Fig [8](#embr201642586-fig-0008){ref-type="fig"}D). In conclusion, these analyses suggest that TLR3 activation during the neonatal stage has a long‐lasting effect on dendritic spine formation at later stages.

![TLR3 activation alters spine morphology *in vitro* and *in vivo*\
ACortical and hippocampal mixed neuronal cultures were transfected with a GFP construct at 12 DIV and treated with poly(I:C) (pIC) at 17 DIV for 24 h. Spine morphology was examined at 18 DIV. Three secondary dendrites of each neuron were selected to analyze the spine density, the width of the spine head, and the spine length. Mean values ± SEM of representatives of three independent experiments are shown. For the saline group, 15 neurons/45 dendrites were examined; for the poly(I:C) group, 16 neurons/48 dendrites were examined. Data were analyzed by unpaired *t*‐test. Scale bar, 20 μm in right upper panel and 5 μm in lower left panel. \*\*\**P* \< 0.0001.BSchematic of the experimental procedure for *in vivo* spine morphology analysis in (C and D). Representative images of somatosensory cortical layer 5 neurons and a high magnification image of a secondary dendrite are shown. Scale bar, 100 μm in the brain section (black) and 10 μm in the dendrite segment (white).C, DSpine morphology of P21 *Thy1‐Yfp* (C) and *Tlr3* ^−/−^; *Thy1‐Yfp* mice (D) after poly(I:C) stimulation at P4 and P5. One secondary dendrite of an apical dendrite of each somatosensory layer 5 cortical neuron was selected to examine the spine morphology. Three mice were analyzed for each group. Saline‐treated *Thy1‐Yfp*, 44 neurons; poly(I:C)‐treated *Thy1‐Yfp*, 43 neurons; saline‐treated *Tlr3* ^−/−^ *;Thy1‐Yfp*, 46 neurons; poly(I:C)‐treated *Tlr3* ^−/−^ *;Thy1‐Yfp*, 50 neurons. Mean values ± SEM are shown. Data were analyzed by unpaired *t*‐test. Scale bars, 5 μm. \*\*\**P* \< 0.0001.](EMBR-18-169-g014){#embr201642586-fig-0008}

Discussion {#embr201642586-sec-0011}
==========

TLR3 is an endosomal TLR that recognizes viral and self dsRNA to trigger antiviral and inflammatory responses [35](#embr201642586-bib-0035){ref-type="ref"}. In this report, we found three unexpected properties of TLR3 signaling. First, MYD88, but not TRIF, is required for TLR3 to control dendritic growth. Second, MYD88 uses its N‐terminal death and intermediate domains, but not the TIR domain, to interact with the TLR3 cytoplasmic region. Third, although TLR3 activation in neurons induces cytokine expression, cytokines are not required for TLR3 to negatively regulate dendritic growth.

TLR3 is known to utilize only TRIF to elicit an antiviral response [23](#embr201642586-bib-0023){ref-type="ref"}, [36](#embr201642586-bib-0036){ref-type="ref"}, and involvement of other adaptor molecules has not been suggested for TLR3‐dependent signaling. Here, in our cultured neurons, the data suggest that TRIF is required for poly(I:C) treatment to induce cytokine expression. However, TRIF‐mediated cytokine production is not required for regulation of dendritic growth. Instead, TLR3 uses MYD88 to control neuronal morphology, indicating that TLR3 uses both TRIF and MYD88 to deliver its downstream signaling. The TRIF‐dependent signaling is needed to regulate cytokine expression. The MYD88‐dependent pathway is crucial to controlling neuronal morphology. It is well known that TLR4 uses both MYD88 and TRIF to induce inflammatory responses [35](#embr201642586-bib-0035){ref-type="ref"}. Recent studies have reported that TLR5 can also use TRIF to deliver signaling in intestinal epithelial cells [37](#embr201642586-bib-0037){ref-type="ref"}, and TLR9 acts through TRIF as well as Sarm1 to promote a tolerogenic response in plasmacytoid dendritic cells and induce apoptosis in neurons, respectively [38](#embr201642586-bib-0038){ref-type="ref"}, [39](#embr201642586-bib-0039){ref-type="ref"}. Therefore, canonical TLR signal pathways may not be applied universally. Distinct cell types and various physiological conditions may alter TLR signal pathways.

The death and TIR domains of MYD88 have been identified to interact with multiple proteins. Fas‐associated protein with death domain (FADD), interleukin‐1 receptor‐associated kinases (IRAKs), and interferon regulatory factor 7 (IRF7) bind to the death domain of MYD88 [40](#embr201642586-bib-0040){ref-type="ref"}, [41](#embr201642586-bib-0041){ref-type="ref"}, [42](#embr201642586-bib-0042){ref-type="ref"}, [43](#embr201642586-bib-0043){ref-type="ref"}. The TIR domain of MYD88 associates with IL‐1R, MYD88‐adapter‐like (MAL, \#32), IRF3, and TLRs (except TLR3) [26](#embr201642586-bib-0026){ref-type="ref"}, [44](#embr201642586-bib-0044){ref-type="ref"}, [45](#embr201642586-bib-0045){ref-type="ref"}. Unlike other TLR--MYD88 interactions, the TLR3 and MYD88 interaction is a TIR domain to death domain association. This kind of TLR3--MYD88 interaction may form a different protein complex to trigger distinct cell responses. The downstream signaling of this TLR3--MYD88 complex needs to be further characterized.

Previous reports indicate that maternal cytokines, such as IL‐6 and IL‐17a, from pregnant mice infected with virus or receiving poly(I:C) stimulation cause abnormal fetal brain development and develop autism‐ and schizophrenic‐like behavior in adult offspring [18](#embr201642586-bib-0018){ref-type="ref"}, [19](#embr201642586-bib-0019){ref-type="ref"}, [32](#embr201642586-bib-0032){ref-type="ref"}. Some viruses are neurotropic and may cross the placenta to infect the fetus, for example, West Nile virus and Zika virus [46](#embr201642586-bib-0046){ref-type="ref"}, [47](#embr201642586-bib-0047){ref-type="ref"}, and these viruses have been suggested to trigger TLR3 signaling [48](#embr201642586-bib-0048){ref-type="ref"}, [49](#embr201642586-bib-0049){ref-type="ref"}. Therefore, both developing neurons and microglia may encounter the invasive virus directly and activate their TLR3 pathway to defend themselves from the foreign pathogens. Indeed, our data suggest that poly(I:C) treatment induces *Tnfa*,*Il1b,* and *Ifnb* expression in cultured neurons, which may be involved in defense against pathogenic infection. However, cytokines produced by neurons upon poly(I:C) stimulation are either inefficient or insufficient to modulate neuronal morphology. Instead, our data suggest that neuronal TLR3 controls expression of a series of autism‐ and schizophrenia‐related genes to regulate neuronal morphology. It is reasonable to speculate that in addition to peripheral and microglial immune responses [21](#embr201642586-bib-0021){ref-type="ref"}, [32](#embr201642586-bib-0032){ref-type="ref"}, [50](#embr201642586-bib-0050){ref-type="ref"}, neuronal TLR3 activation may also contribute to altering neuronal and brain function. It will be important to further verify the effect of neuronal TLR3 on brain development and function using neuron‐specific *Tlr3*‐knockout mice.

In this report, we provide evidence that the protein levels of DISC1 were noticeably reduced after poly(I:C) treatment. Overexpression of wild‐type DISC1, but not a mutant identified from schizophrenia patients, effectively rescues the dendritic defects caused by TLR3 activation, suggesting a critical role of DISC1 in TLR3‐regulated neurodevelopment. *DISC1* is associated with schizophrenia, autism, bipolar disorders, and depression [51](#embr201642586-bib-0051){ref-type="ref"}, [52](#embr201642586-bib-0052){ref-type="ref"}, [53](#embr201642586-bib-0053){ref-type="ref"}, [54](#embr201642586-bib-0054){ref-type="ref"}. It is a versatile molecule involved in neurogenesis, postmitotic neural migration, dendritic arborization, dendritic spine formation, and synaptic plasticity [55](#embr201642586-bib-0055){ref-type="ref"}, [56](#embr201642586-bib-0056){ref-type="ref"}, [57](#embr201642586-bib-0057){ref-type="ref"}, [58](#embr201642586-bib-0058){ref-type="ref"}, [59](#embr201642586-bib-0059){ref-type="ref"}. DISC1 associates with microtubule‐associated proteins, motor molecules, signaling proteins, and RNA binding proteins to influence cytoskeleton function, protein and RNA trafficking, and neuronal development and plasticity [59](#embr201642586-bib-0059){ref-type="ref"}, [60](#embr201642586-bib-0060){ref-type="ref"}, [61](#embr201642586-bib-0061){ref-type="ref"}, [62](#embr201642586-bib-0062){ref-type="ref"}, [63](#embr201642586-bib-0063){ref-type="ref"}, [64](#embr201642586-bib-0064){ref-type="ref"}. Reduction in DISC1 expression by TLR3 activation may then influence the downstream pathways of DISC1 and result in neurodevelopmental impairment. It would certainly be interesting to further determine whether a specific downstream effector of DISC1 is particularly sensitive to TLR3 activation.

Several studies have suggested that environment--genetic interactions play an important role in neurodevelopmental disorders. For instance, maternal immune activation and *Tsc2* haploinsufficiency work together to disturb social behavior in offspring [65](#embr201642586-bib-0065){ref-type="ref"}. Expression of the *Disc1* mutant in mice exacerbates the behavioral defects induced by poly(I:C) injections at prenatal stages [66](#embr201642586-bib-0066){ref-type="ref"}, [67](#embr201642586-bib-0067){ref-type="ref"}, [68](#embr201642586-bib-0068){ref-type="ref"}. Our study indicates regulation of DISC1 expression by TLR3 activation, implying that environmental factors, such as viral infection, regulate expression of the genes associated with psychiatric disorders and influence neurodevelopment. Our findings further support that genetic polymorphism plus environmental stimulations may contribute to the diversity of psychiatric disorders.

Our research shows that, compared with the saline control group, poly(I:C)‐treated mice had a higher dendritic spine density at P21, which resembles one of the common features of autism spectrum disorders, namely impaired synapse elimination during maturation [69](#embr201642586-bib-0069){ref-type="ref"}, [70](#embr201642586-bib-0070){ref-type="ref"}. Since TLR3 activation at P4 and P5 influences dendritic spine density and morphology at P21, this result indicates a long‐term effect of TLR3 activation on neurodevelopment. Recently, epigenetic reprogramming has been shown to control long‐lasting effects of innate immune responses in peripheral tissues [71](#embr201642586-bib-0071){ref-type="ref"}. It is very likely that neuronal innate immunity uses a similar mechanism to control gene expression over a long‐lasting period and thus impact on neural plasticity and cognition, which presents a very intriguing subject for future study.

In the current study, the RNA levels of *Auts2*,*Disc1*,*Fmr1*, and *Ube3a* were noticeably reduced upon TLR3 activation. However, only DISC1 proteins were obviously decreased 24 h after TLR3 activation. It is unclear why only DISC1 protein levels were altered. Perhaps, the other proteins are more stable and thus take a longer time to reflect the effect of RNA reduction. If TLR3 does alter the protein levels of these genes, these proteins may impact on other neuronal phenotypes or responses. It would be intriguing to examine these possibilities in the future.

A previous study showed that poly(I:C) treatment did not influence *Disc1* expression in mice [72](#embr201642586-bib-0072){ref-type="ref"}, which conflicts with the findings of our study. There are at least two possibilities to explain the discrepancy. First, an outbred strain of ICR mice was used in the previous paper, whereas we used mice in the C57BL/6 background in our study. Different genetic backgrounds may result in different responses to poly(I:C) stimulation. In particular, ICR mice, but not C57BL/6, have been shown to carry a 25‐bp deletion in the *Disc1* gene and cannot express full‐length DISC1 proteins [73](#embr201642586-bib-0073){ref-type="ref"}. Second, the experimental procedures between the previous work and our study differ. In our study, a single shot of poly(I:C) was intraperitoneally injected into neonatal mice at P5. Six hours later, cortex and hippocampus were harvested for quantitative RT‐PCR. In the previous work, poly(I:C) was injected once per day from P2 to P6. Only the hippocampus was harvested for quantitative RT‐PCR 2 and 24 h after the last injection. These differences may also contribute to the differences between our results and those of the previous study.

In conclusion, our data suggest that TLR3 uses a non‐canonical MYD88‐dependent pathway to control *Disc1* expression and cell‐autonomously regulate neuronal morphology. Neuronal innate immunity may regulate neuronal morphology in response to exogenous immune challenge as well as intrinsic developmental signals or stress responses.

Materials and Methods {#embr201642586-sec-0012}
=====================

Animals and treatments {#embr201642586-sec-0013}
----------------------

*Thy1‐Yfp* [74](#embr201642586-bib-0074){ref-type="ref"}, *Tlr3* ^−/−^ [75](#embr201642586-bib-0075){ref-type="ref"}, *Trif*‐mutant [23](#embr201642586-bib-0023){ref-type="ref"}, *Myd88* ^−/−^ [24](#embr201642586-bib-0024){ref-type="ref"}, *Il6* ^−/−^ [76](#embr201642586-bib-0076){ref-type="ref"}, and *Tnfa* ^−/−^ [77](#embr201642586-bib-0077){ref-type="ref"} mice in a C57BL/6 background were purchased from Jackson Laboratory. Animals were housed in the animal facility of the Institute of Molecular Biology, Academia Sinica, with a 12‐h light/12‐h dark cycle and controlled temperature and humidity. All animal experiments were performed with the approval of the Academia Sinica Institutional Animal Care and Utilization Committee and in strict accordance with its guidelines and those of the Council of Agriculture Guidebook for the Care and Use of Laboratory Animals. For cortical and hippocampal mixed neuronal cultures, E16‐17 mouse embryos of both genders were used. For *in vivo* neuronal morphology analysis, *Thy1‐Yfp* and *Tlr3* ^−/−^ *;Thy1‐Yfp* mice of both genders received an intraperitoneal injection of saline or 5 mg/kg poly(I:C) (HMW; InvivoGen) daily at P4 and P5. The brains were harvested at P7 for dendritic arbor analysis and at P21 for examining spine morphology. Neuronal morphology was monitored with YFP signal.

Cell culture, transfection, drug treatment, immunoprecipitation, and immunoblotting {#embr201642586-sec-0014}
-----------------------------------------------------------------------------------

Transfections of HEK293T cells were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer\'s instructions [30](#embr201642586-bib-0030){ref-type="ref"}. Mouse cortical and hippocampal mixed neurons were cultured in Neurobasal medium/DMEM (1:1) with B27 supplement and transfected using calcium phosphate precipitation methods as described [20](#embr201642586-bib-0020){ref-type="ref"}, [30](#embr201642586-bib-0030){ref-type="ref"}. Cotransfected or coexpressed GFP was used to outline neuronal morphology. Neurons were treated with 10 μg/ml poly(I:C) for 24 h before being harvested. Immunoprecipitation and immunoblotting were performed as described [30](#embr201642586-bib-0030){ref-type="ref"}, except that the protein signals were visualized and quantified using ImageQuant LAS 4000 with the software ImageQuant LAS 4000 Biomolecular Imager (GE Healthcare).

Immunocytochemistry and immunohistochemistry {#embr201642586-sec-0015}
--------------------------------------------

Immunostaining of cultured neurons and 100*‐*μm*‐*thick brain sections was performed as described [30](#embr201642586-bib-0030){ref-type="ref"}. Immunofluorescent images of cultured neurons were visualized at room temperature with a fluorescence microscope (Axioimage M2; Zeiss) equipped with a 20×/NA 0.80 (Plan‐Apochromat) objective lens and acquired using a cooled charge‐coupled device camera (Rolera EM‐C^2^; QImaging) with Zen software (Zeiss). For brain sections, neuronal images were captured at room temperature with a confocal microscope (LSM 700, Zeiss) equipped with a 20×/NA 0.80 (Plan‐Apochromat) objective lens and Zen acquisition and analysis software (Zeiss). The images were processed using Photoshop (Adobe) with minimal adjustment of brightness or contrast applied to the entire images. The camera lucida drawings were performed with ImageJ.

*In utero* electroporation {#embr201642586-sec-0016}
--------------------------

*In utero* electroporation was performed as previously described with slight modifications [22](#embr201642586-bib-0022){ref-type="ref"}. Briefly, pregnant wild‐type B6 mice were exposed to 1.8% isoflurane in oxygen during surgery and the embryos at embryonic day 15 were used for *in vivo* electroporation of the cortex. Control plasmid pCAGEN (Addgene) or pCAG‐Myc‐DISC1 was mixed with pCAG‐GFP (Addgene) in a 3:1 ratio and injected into one of the lateral ventricles of embryo brain using a glass micropipette. The embryonic brain then received five pulses (30 V for 50 ms) of electric shock with 950‐ms intervals using an ECM830 square wave pulse generator (BTX, Harvard Apparatus). Poly(I:C) injection, perfusion, brain fixation/sectioning, and neuronal image acquisition were performed as described in the previous sections.

Neuronal morphometry {#embr201642586-sec-0017}
--------------------

For axons, the lengths of both the primary axon (i.e. the longest axon) and total axons were measured. For dendrites, the total dendrite length was measured, including primary dendrites and all dendritic branches, and the number of dendritic tips was counted. For neuronal morphology in brains, assessment of the intersection number in Sholl analysis [78](#embr201642586-bib-0078){ref-type="ref"} was also undertaken. For *in vivo* spine analysis, secondary dendrites of apical dendrites of layer 5 cortical neurons from the somatosensory cortex were chosen to examine spine density, the width of the spine head, and spine length. To minimize the effects of bias, the critical experiments were performed blind by relabeling the samples with the assistance of other laboratory members. For cultured neurons, all experiments were repeated at least three times. For each repeat, at least 30 neurons were randomly picked from each group for analysis. The conclusions of all results shown in this manuscript can be repeated in three independent experiments. For *in vivo* analysis, at least 30 neurons collected from three or more mice were used for analysis. All measurements were carried out using the software ImageJ.

Quantitative RT‐PCR {#embr201642586-sec-0018}
-------------------

Wild‐type (WT), *Tlr3* ^−/−^ *,* and *Myd88* ^−/−^ cultured neurons were treated with 10 μg/ml poly(I:C) for 6 h before harvesting. To quantify gene expression in brains, WT mice received an intraperitoneal injection of saline or 5 mg/kg poly(I:C) at P5. Six hours after injection, mouse cortex and hippocampus were harvested for total RNA extraction using Trizol reagent according to the manufacturer\'s instructions (Invitrogen) followed by DNase I digestion (New England BioLabs). Reverse transcription and quantitative RT‐PCR analysis was performed using the Transcriptor First Strand cDNA Synthesis Kit (Roche) with an oligo(dT)18 primer and the Universal ProbeLibrary probes (UPL; Roche) system, respectively [20](#embr201642586-bib-0020){ref-type="ref"}, [22](#embr201642586-bib-0022){ref-type="ref"}. Primer sets for cytokines were as described [20](#embr201642586-bib-0020){ref-type="ref"}. The primer sets for neurodevelopmental disease genes and internal control *Hprt* for quantitative RT‐PCR analysis are listed in [Table EV1](#embr201642586-sup-0002){ref-type="supplementary-material"}. Levels of target mRNA were normalized to levels of *Hprt* mRNA measured at the same time on the same reaction plate.

Antibodies and plasmids {#embr201642586-sec-0019}
-----------------------

Detailed information on the antibodies and DNA constructs used in this report is summarized in [Tables EV2](#embr201642586-sup-0003){ref-type="supplementary-material"} and [EV3](#embr201642586-sup-0004){ref-type="supplementary-material"}, respectively.

Statistical analysis {#embr201642586-sec-0020}
--------------------

Statistical analyses were performed using GraphPad Prism software. For animal studies, all available mice were subjected to analysis and no randomization was performed. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications [20](#embr201642586-bib-0020){ref-type="ref"}, [30](#embr201642586-bib-0030){ref-type="ref"}, [79](#embr201642586-bib-0079){ref-type="ref"}, [80](#embr201642586-bib-0080){ref-type="ref"}. No sample was excluded from the analyses. The majority of data met the assumption (normal distribution) of statistical tests, except Fig [2](#embr201642586-fig-0002){ref-type="fig"}A Tip/pIC, 4A Tnfa/Sal and Ifnb/Sal, 4B Tip/Sal, 4C Tip/pIC, 7C Tip/pIC, 8A width and length, 8C width and length, and 8D width and length. Experiments were performed blind by relabeling the samples with the assistance of other laboratory members. For two‐group experiments, the unpaired *t*‐test was used. For experiments with more than two groups, one‐way ANOVA with *post hoc* Bonferroni correction was applied. For the Sholl analysis, two‐way ANOVA with *post hoc* Bonferroni correction was used. Data are presented as the mean ± SEM.
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